Virpax Announces Results of Maximum Tolerated Dose Study for Probudur™
Virpax Pharmaceuticals Reports 2023 Year-End Results [Yahoo! Finance]
Virpax Pharmaceuticals Reports 2023 Year-End Results
Scilex Holding Company's Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of S
Scilex and Sorrento settle with Virpax and its founder Anthony Mack [Seeking Alpha]